These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies. Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515 [TBL] [Abstract][Full Text] [Related]
25. [Current therapeutic attitude toward endocrine exophthalmos]. Trottier M Union Med Can; 1966 Nov; 95(11):1289-90. PubMed ID: 4167016 [No Abstract] [Full Text] [Related]
26. [Endocrine exophthalmos. New nosological proposal and current therapeutic trends]. Maiello M Recenti Prog Med; 1980 Oct; 69(4):410-30. PubMed ID: 7006014 [No Abstract] [Full Text] [Related]
27. [Controversies in the pathogenesis and medical treatment of thyroid ophthalmopathy]. Boschi A; Detry-Morel M J Fr Ophtalmol; 1994; 17(10):620-8. PubMed ID: 7822703 [No Abstract] [Full Text] [Related]
28. Reliability of exophthalmos measurement and the exophthalmometry value distribution in a healthy Dutch population and in Graves' patients. An exploratory study. Mourits MP; Lombardo SH; van der Sluijs FA; Fenton S Orbit; 2004 Sep; 23(3):161-8. PubMed ID: 15545129 [TBL] [Abstract][Full Text] [Related]
29. Some important ophthalmological aspects of endocrine orbitopathy. Goder GJ Radiobiol Radiother (Berl); 1987; 28(5):539-41. PubMed ID: 3441596 [No Abstract] [Full Text] [Related]
34. The pathogenesis of endocrine exophthalmos: a short review. Doniach D Proc R Soc Med; 1977 Oct; 70(10):695-8. PubMed ID: 200947 [No Abstract] [Full Text] [Related]